This inventor holds 1 USPTO granted patent. Top assignee: Sri International. Active years: 1980.
Company Filing History:
Years Active: 1980
Title: The Innovations of Donald A. Berkowitz
Introduction
Donald A. Berkowitz is a notable inventor based in El Cerrito, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel derivatives of morphine compounds. His work has implications for pain management and addiction treatment.
Latest Patents
Berkowitz holds a patent for N-.alpha.Methylcyclopropylmethyl derivatives of normorphine and novel N-sec-alkyl derivatives of norcodeine and normorphine. These derivatives are characterized by a sec-alkyl group containing either four or five carbon atoms. Specifically, the patent includes derivatives where the sec-alkyl group is 2-butyl, 3-pentyl, α-methylallyl, and α-methylcyclopropylmethyl. The normorphine derivatives exhibit strong agonist potency combined with strong antagonist qualities, indicating a low potential for addiction. Additionally, the norcodeine analogs serve as useful intermediates in preparing corresponding normorphine compounds.
Career Highlights
Berkowitz is associated with SRI International, a research institute known for its innovative work in various scientific fields. His career has been marked by a focus on developing compounds that can improve therapeutic outcomes while minimizing addiction risks.
Collaborations
Throughout his career, Berkowitz has collaborated with notable colleagues, including Joseph I. DeGraw and John A. Lawson. These collaborations have contributed to the advancement of research in pharmaceutical sciences.
Conclusion
Donald A. Berkowitz's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of research in developing safer pain management options. His work continues to influence the landscape of addiction treatment and pharmaceutical development.